Advertisement

Ads Placeholder
Loading...

Syngene International Limited

SYNGENE.NSNSE
Healthcare
Biotechnology
391.10
-5.30(-1.34%)
Indian Market opens in 34h 48m

Syngene International Limited (SYNGENE.NS) Stock Overview

Explore Syngene International Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap157.1B
P/E Ratio45.03
EPS (TTM)$8.72
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 Month$456.19
3 Months$335.96
1 Year Target$763.12

SYNGENE.NS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Syngene International Limited (SYNGENE.NS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 36.48, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $763.12.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 45.03 and a market capitalization of 157.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.34%
5-Day Change
-6.66%
1-Month Change
-2.40%
3-Month Change
-40.60%
6-Month Change
-38.46%
Year-to-Date (YTD) Change
-39.85%
1-Year Change
-47.65%
3-Year Change
-33.28%
5-Year Change
-30.77%
All-Time (Max) Change
151.88%

Contact Information

91 80 2808 2808
Biocon SEZ, Biocon Park,, Bengaluru, NaN, 560099

Company Facts

65,100 Employees
IPO DateAug 11, 2015
CountryIN
Actively Trading

Frequently Asked Questions